Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Vallon Pharmaceuticals Inc (VLON)

Vallon Pharmaceuticals Inc (VLON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Vallon Pharmaceuticals Inc TWO LOGAN SQUARE 100 N. 18TH STREET SUITE 300 PHILADELPHIA PA 19103 USA

www.vallon-pharma.com P: 267-607-8255

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Vallon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on the development of novel drugs which are designed to deter abuse in the treatment of CNS disorders. Vallon Pharmaceuticals Inc. is based in PHILADELPHIA, PA.

Key Statistics

Overview:

Market Capitalization, $K 5,393
Enterprise Value, $K 1,613
Shares Outstanding, K 13,482
Float, K 8,453
% Float 62.70%
Short Volume Ratio 0.58
% of Insider Shareholders 37.30%
% of Institutional Shareholders 8.74%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -7,020 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -1,583 K

Growth:

1-Year Return -64.60%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.10 on 02/24/23
Next Earnings Date 05/08/23
Earnings Per Share ttm -0.42
EPS Growth vs. Prev Qtr 16.67%
EPS Growth vs. Prev Year 78.26%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-30 on 04/24/23

VLON Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -230.48%
Return-on-Assets % -124.89%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.18
Book Value/Share 0.00
Interest Coverage -235.00
60-Month Beta -1.14
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar